Quick Heal Technologies Ltd (BOM:539678)
₹ 606.2 -4.95 (-0.81%) Market Cap: 32.68 Bil Enterprise Value: 30.79 Bil PE Ratio: 102.23 PB Ratio: 7.47 GF Score: 72/100

Q1 2025 Quick Heal Technologies Ltd Earnings Call Transcript

Jul 29, 2024 / 10:30AM GMT
Release Date Price: ₹589.6 (-1.57%)

Key Points

Positve
  • Quick Heal Technologies Ltd (BOM:539678) reported a 37% year-on-year growth for Q1 FY '25.
  • The company successfully prevented 128 million attacks, including over 400,000 ransomware attacks in Q1.
  • Launch of new products like on-premises EDR and Horizon two products (XDR, zero-trust) has generated good customer traction.
  • The company has a strong balance sheet and remains a cash-positive entity.
  • Attrition rates are on a steady decline, indicating improved employee retention.
Negative
  • There was a 12% decline in revenues on a quarter-on-quarter basis due to Q1 being a sluggish quarter and deferment of government deals.
  • R&D expenses are high, constituting 49% of revenue, which may impact short-term profitability.
  • The company faces cyclicality in revenue, with Q1 traditionally being the weakest quarter.
  • Despite the growth in enterprise business, the company still faces strong competition from established global cybersecurity companies.
  • The implementation of the DPDP Act in India may require significant adjustments and investments from the company.
Operator

Ladies and gentlemen, good day, and welcome to Quick Heal Technologies Limited Q1 FY '25 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Anuj Sonpal from Valorem Advisors.

Thank you, and over to you, sir

Anuj Sonpal
Valorem Advisors - Investor Relations

Good evening, everybody, and a very warm welcome to you all. My name is Anuj Sonpal from Valorem Advisors. We represent the Investor Relations of Quick Heal Technologies Limited. On behalf of the company, I would like to thank you all for participating in the company's earnings conference call for the first quarter of financial year ending 2025. Before we begin, let me mention a short cautionary statement. Some of the statements made in today's earnings conference call may be forward-looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from those anticipated.

Such statements are based on management's beliefs as well as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot